Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
Clinical trial NCT00544804 · COMPLETED
Trial details
- NCT number
- NCT00544804
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2013-06-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.